Evidence map›Paper›PMID 36332029›Full record

ArticleScience advances2022

The HUSH complex controls brain architecture and protocadherin fidelity.

Astrid Hagelkruys, Marion Horrer, Jasmin Taubenschmid-Stowers, Anoop Kavirayani, Maria Novatchkova, Michael Orthofer, Tsung-Pin Pai, Domagoj Cikes, Sergei Zhuk, Meritxell Balmaña and 9 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. A unified photosensitizer platform forbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Astrid HagelkruysInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0003-3015-4038
Marion HorrerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0001-6565-971X
Jasmin Taubenschmid-StowersInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0003-3377-2026
Anoop KavirayaniVienna Biocenter Core Facilities (VBCF), Vienna, Austria.ORCID 0000-0003-3874-3101
Maria NovatchkovaInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Michael OrthoferInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Tsung-Pin PaiInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Domagoj CikesInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0003-0350-5672
Sergei ZhukInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0002-0228-8373
Meritxell BalmañaInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0001-6587-3900
Christopher EskInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0003-1833-0801
Rubina KoglgruberInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0001-6959-0780
Paul MoesenederInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.
Jelena LazovicInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0001-7646-6104
Lydia M ZopfVienna Biocenter Core Facilities (VBCF), Vienna, Austria.
Shane J F CroninInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0003-4222-5315
Ulrich EllingInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0002-4514-2809
Jürgen A KnoblichInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0002-6751-3404
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.ORCID 0000-0002-8194-3777
Institute of Molecular Biotechnology · ATVienna Biocenter · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The HUSH (human silencing hub) complex contains the H3K9me3 binding protein M-phase phosphoprotein 8 (MPP8) and recruits the histone methyltransferase SETDB1 as well as Microrchidia CW-type zinc finger protein 2 (MORC2). Functional and mechanistic studies of the HUSH complex have hitherto been centered around SETDB1 while the in vivo functions of MPP8 and MORC2 remain elusive. Here, we show that genetic inactivation of

Identifiers

PMID36332029
PMCPMC9635835
OpenAlexW4308340884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.